Drugs / CTS21166
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00621010 | Jun 2007 → Feb 2008 | Alzheimer disease | CoMentis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTS21166 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00621010 ↗ |
| Known as | ZPQ-21166 | “CTS21166 (ZPQ-21166)” NCT00621010 ↗ |
| Route | Intravenous | “Administered Intravenously” NCT00621010 ↗ |